What is ReposiTrak, Inc.'s earnings per share (EPS)?

ReposiTrak, Inc. (TRAK) reported diluted earnings per share of $0.39 for fiscal year 2026. This represents a 11.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ReposiTrak, Inc. (TRAK) Financials

TRAK

FY2026 annual

Revenue $23.3M +3.0% YoY

Net Income $7.6M +8.5% YoY

EPS (Diluted) $0.39 +11.4% YoY

Free Cash Flow $8.2M -2.3% YoY

Market Cap $133.2M as of Oct 23, 2026

Price / Sales 5.7x on $23.3M revenue, FY2026

Price / Earnings 17.6x on $7.6M net income, FY2026

Price / Book 2.5x on $52.3M equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Sep 28, 2026 Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Sep 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the TRAK SEC filings page.

ReposiTrak, Inc. (TRAK) reported $23.3M in revenue for fiscal year 2026, up 3.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TRAK FY2026 2026-10-22

High-margin operations convert earnings into cash, while costs improve faster than sales and short-term obligations rise.

From FY2024 to FY2026, revenue increased 13.9%, while operating income increased 56.1%, revealing operating leverage rather than mere top-line expansion. Gross margin reached 85.8% and operating margin 33.7% in FY2026, so improvement occurred both before and after operating expenses.

FY2026 operating cash flow was $8.2M, while capital expenditures consumed only 0.1% of revenue. That light reinvestment burden leaves cash generation largely unobstructed; operating cash flow converted at 111.1% of net income.

Liabilities grew 47.5% in FY2026 while assets grew 10.0%, showing obligations are expanding faster than the asset base. The current ratio fell from 6.1x to 3.9x, indicating less short-term cushion than FY2025 despite substantial reported current-asset coverage.

Financial Health Signals

Financial Health Score 85/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of ReposiTrak, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

ReposiTrak, Inc. has an operating margin of 33.7%, meaning the company retains $34 of operating profit per $100 of revenue. This strong profitability earns a score of 91/100, reflecting efficient cost management and pricing power. This is up from 27.6% the prior year.

Growth

ReposiTrak, Inc.'s revenue grew a modest 3.0% year-over-year to $23.3M. This slow but positive growth earns a score of 56/100.

Leverage

ReposiTrak, Inc. carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.85, ReposiTrak, Inc. holds $3.85 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 86/100.

Cash Flow

ReposiTrak, Inc. converts 35.3% of revenue into free cash flow ($8.2M). This strong cash generation earns a score of 96/100.

Returns

ReposiTrak, Inc. earns a strong 14.5% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 80/100. This is up from 14.1% the prior year.

Altman Z-Score Safe

10.46

ReposiTrak, Inc. scores 10.46, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $133.2M against total liabilities of $8.6M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

ReposiTrak, Inc. passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed

1.09x

For every $1 of reported earnings, ReposiTrak, Inc. generates $1.09 in operating cash flow ($8.2M OCF vs $7.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

203.81x

ReposiTrak, Inc. earns $203.81 in operating income for every $1 of interest expense ($7.8M vs $38K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.6M

YoY-3.2%

QoQ-5.2%

ReposiTrak, Inc. generated $5.6M in revenue in Q4 2026. This represents a decrease of 3.2% from the same quarter a year earlier. Against the prior quarter it is down 5.2%.

EBITDA

$2.0M

YoY+2.2%

QoQ-16.2%

ReposiTrak, Inc.'s EBITDA was $2.0M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 2.2% from the same quarter a year earlier. Against the prior quarter it is down 16.2%.

Net Income

$2.1M

YoY+15.7%

QoQ+4.7%

ReposiTrak, Inc. reported $2.1M in net income in Q4 2026. This represents an increase of 15.7% from the same quarter a year earlier. Against the prior quarter it is up 4.7%.

EPS (Diluted)

$0.11

YoY+22.2%

QoQ+10.0%

5Y CAGR+17.1%

ReposiTrak, Inc. earned $0.11 per diluted share (EPS) in Q4 2026. This represents an increase of 22.2% from the same quarter a year earlier. Against the prior quarter it is up 10.0%.

Cash & Balance Sheet

Free Cash Flow

$2.4M

YoY+43.1%

QoQ+13.3%

ReposiTrak, Inc. generated $2.4M in free cash flow in Q4 2026, representing cash available after capex. This represents an increase of 43.1% from the same quarter a year earlier. Against the prior quarter it is up 13.3%.

Cash & Debt

$27.3M

YoY-4.6%

QoQ+3.2%

5Y CAGR+2.5%

10Y CAGR+9.1%

ReposiTrak, Inc. held $27.3M in cash against $61K in long-term debt as of Q4 2026.

Shares Outstanding

18M

YoY-0.5%

QoQ+0.2%

5Y CAGR-1.3%

ReposiTrak, Inc. had 18M shares outstanding in Q4 2026. This represents a decrease of 0.5% from the same quarter a year earlier. Against the prior quarter it is up 0.2%.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

Gross Margin

85.7%

YoY+1.5pp

QoQ-0.6pp

ReposiTrak, Inc.'s gross margin was 85.7% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.6 percentage points.

Operating Margin

33.7%

YoY+6.2pp

QoQ-4.5pp

ReposiTrak, Inc.'s operating margin was 33.7% in Q4 2026, reflecting core business profitability. This is up 6.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.5 percentage points.

Net Margin

37.3%

YoY+6.1pp

QoQ+3.5pp

ReposiTrak, Inc.'s net profit margin was 37.3% in Q4 2026, showing the share of revenue converted to profit. This is up 6.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.5 percentage points.

Return on Equity

4.0%

YoY+0.3pp

QoQ0.0pp

ReposiTrak, Inc.'s quarterly ROE was 4.0% in Q4 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.3 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Capital Allocation

Share Buybacks

YoY-100.0%

QoQ-100.0%

ReposiTrak, Inc. repurchased no shares in Q4 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Capital Expenditures

$5K

YoY-32.4%

QoQn/m

ReposiTrak, Inc. invested $5K in capex in Q4 2026, funding long-term assets and infrastructure. This represents a decrease of 32.4% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

R&D Spending

Not reported for Q4 2026.

TRAK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TRAK quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$23.3M+3.0%	$22.6M+10.5%	$20.5M+7.1%	$19.1M+5.8%	$18.0M-14.1%	$21.0M+4.8%	$20.0M-5.3%	$21.2M-3.9%	$22.0M+16.4%	$18.9M+35.2%	$14.0M+2.7%	$13.6M+14.4%	$11.9M+5.4%	$11.3M+12.1%	$10.1M
Cost of Revenue	$3.3M-10.2%	$3.7M+7.8%	$3.4M+3.2%	$3.3M+3.8%	$3.2M-53.7%	$6.9M-1.6%	$7.0M+20.0%	$5.8M-11.5%	$6.6M+23.9%	$5.3M+24.3%	$4.3M-18.6%	$5.3M+3.3%	$5.1M+13.3%	$4.5M-2.0%	$4.6M
Gross Profit	$20.0M+5.6%	$18.9M+11.1%	$17.0M+7.9%	$15.8M+6.3%	$14.9M+5.2%	$14.1M+8.3%	$13.0M-15.0%	$15.3M-0.7%	$15.4M+13.4%	$13.6M+40.0%	$9.7M+15.9%	$8.4M+22.7%	$6.8M+0.2%	$6.8M+23.8%	$5.5M
SG&A Expenses	$11.5M+0.4%	$11.4M+5.8%	$10.8M+12.5%	$9.6M+0.5%	$9.6M-6.3%	$10.2M-4.8%	$10.7M-0.2%	$10.7M-4.9%	$11.3M+22.4%	$9.2M+8.2%	$8.5M-16.5%	$10.2M+19.5%	$8.6M+54.7%	$5.5M-1.1%	$5.6M
Operating Income	$7.8M+26.0%	$6.2M+23.9%	$5.0M-1.3%	$5.1M+15.3%	$4.4M+52.6%	$2.9M+95.7%	$1.5M-63.0%	$4.0M+13.4%	$3.5M-9.9%	$3.9M+467.5%	$687Kn/m	-$4.1Mn/m	-$2.6M-751.1%	$398Kn/m	-$973K
EBITDA	$8.5M+13.5%	$7.5M+20.4%	$6.2M+0.7%	$6.2M+16.6%	$5.3M+35.2%	$3.9M+71.5%	$2.3M-50.3%	$4.6M+10.6%	$4.2M-5.4%	$4.4M+267.2%	$1.2Mn/m	-$3.3Mn/m	-$1.7M-231.8%	$1.3Mn/m	-$73K
Interest Expense	$38K-20.9%	$49K+72.8%	$28K-53.8%	$61K+37.7%	$44K-58.5%	$107K+57.5%	$68K+58.7%	$43K-74.4%	$167K	N/A	N/A	N/A	-$103K-172.9%	$141K-31.4%	$205K
Income Tax	$1.9M+188.5%	$676K+80.5%	$374K+16.5%	$321K+147.3%	$130K+69.0%	$77K+83.4%	$42K-70.6%	$143K+35.4%	$105K-2.0%	$108Kn/m	$0n/m	$0n/m	$0	N/A	N/A
Net Income	$7.6M+8.5%	$7.0M+17.1%	$6.0M+6.6%	$5.6M+39.6%	$4.0M-2.8%	$4.1M+158.4%	$1.6M-59.2%	$3.9M+14.5%	$3.4M-9.8%	$3.8M0.0%	$3.8Mn/m	-$3.8Mn/m	-$2.5M-1067.1%	$257Kn/m	-$859K
EPS (Basic)	$0.41+13.9%	$0.36+20.0%	$0.30+11.1%	$0.27+50.0%	$0.180.0%	$0.18+260.0%	$0.05-70.6%	$0.17+21.4%	$0.14-6.7%	$0.15n/m	$0.00n/m	-$0.38n/m	-$0.19n/m	-$0.05n/m	-$0.14
EPS (Diluted)	$0.39+11.4%	$0.35+20.7%	$0.29+7.4%	$0.27+50.0%	$0.180.0%	$0.18+260.0%	$0.05-68.8%	$0.16+14.3%	$0.14-6.7%	$0.15n/m	$0.00n/m	-$0.38n/m	-$0.19n/m	-$0.05n/m	-$0.14
Diluted Shares (Avg)	19M-0.8%	19M+1.1%	19M+0.9%	19M-3.2%	19M-1.9%	20M-0.5%	20M-2.5%	20M+0.4%	20M+0.1%	20M+5.8%	19M+10.2%	17M+4.0%	17M+26.2%	13M	N/A

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Revenue	$5.6M-3.2%	$5.9M-0.5%	$5.9M+6.7%	$6.0M+9.7%	$5.8M+11.1%	$5.9M+16.3%	$5.5M+7.1%	$5.4M+7.5%
Cost of Revenue	$796K-12.4%	$803K-11.9%	$854K-14.8%	$854K-0.6%	$908K+7.4%	$912K+9.6%	$1.0M+3.0%	$859K+12.1%
Gross Profit	$4.8M-1.5%	$5.1M+1.6%	$5.0M+11.5%	$5.1M+11.7%	$4.9M+11.9%	$5.0M+17.6%	$4.5M+8.1%	$4.6M+6.7%
SG&A Expenses	$2.8M-3.9%	$2.7M-4.6%	$3.0M+4.6%	$3.0M+5.6%	$2.9M+7.5%	$2.9M+6.0%	$2.8M+8.4%	$2.8M+1.3%
Operating Income	$1.9M+18.6%	$2.3M+24.5%	$1.8M+34.4%	$1.9M+28.0%	$1.6M+20.1%	$1.8M+43.3%	$1.4M+9.0%	$1.5M+23.3%
EBITDA	$2.0M+2.2%	$2.3M+9.8%	$2.0M+23.2%	$2.1M+21.4%	$1.9M+19.3%	$2.1M+37.8%	$1.7M+7.5%	$1.8M+16.7%
Interest Expense	$9K-37.3%	$9K-28.3%	$9K-21.8%	$11K+11.4%	$14K+119.8%	$13K+59.5%	$12K+58.8%	$10K+60.3%
Income Tax	$600K+168.1%	$450K+200.1%	$450K+195.8%	$450K+200.0%	$224K+123.8%	$150K+149.9%	$152K+33.4%	$150K+49.3%
Net Income	$2.1M+15.7%	$2.0M+1.0%	$1.7M+8.7%	$1.8M+9.3%	$1.8M+13.8%	$2.0M+26.8%	$1.6M+6.9%	$1.7M+20.8%
EPS (Basic)	$0.12+33.3%	$0.11+10.0%	$0.09+12.5%	$0.10+11.1%	$0.09+12.5%	$0.10+25.0%	$0.08+14.3%	$0.09+28.6%
EPS (Diluted)	$0.11+22.2%	$0.100.0%	$0.09+12.5%	$0.09+12.5%	$0.09+12.5%	$0.10+25.0%	$0.08+14.3%	$0.08+14.3%
Diluted Shares (Avg)	N/A	19M-1.6%	19M-0.5%	19M+0.1%	N/A	19M+1.0%	19M+1.8%	19M+1.4%

Not reported in any period shown, so not listed: R&D Expenses.

TRAK Balance Sheet

TRAK quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$60.9M+10.0%	$55.3M+7.2%	$51.6M+2.0%	$50.6M+2.6%	$49.3M-10.4%	$55.0M+3.0%	$53.4M+0.9%	$52.9M+7.4%	$49.3M+7.4%	$45.9M+19.0%	$38.6M+6.0%	$36.4M+114.9%	$16.9M+6.3%	$15.9M+33.5%	$11.9M
Current Assets	$32.8M-2.8%	$33.7M+15.0%	$29.3M+7.4%	$27.3M+2.6%	$26.6M-10.5%	$29.7M+9.4%	$27.1M+2.3%	$26.5M+11.9%	$23.7M+26.9%	$18.7M+25.7%	$14.9M+10.8%	$13.4M+107.8%	$6.5M+0.9%	$6.4M+79.5%	$3.6M
Cash & Equivalents	$27.3M-4.6%	$28.6M+13.6%	$25.2M+4.8%	$24.0M+11.8%	$21.5M-10.8%	$24.1M+18.3%	$20.3M+9.3%	$18.6M+25.0%	$14.9M+6.0%	$14.1M+22.8%	$11.4M+1.0%	$11.3M+237.8%	$3.4M-7.3%	$3.6M+226.9%	$1.1M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Accounts Receivable	$4.6M+11.6%	$4.1M+12.4%	$3.7M+45.8%	$2.5M-20.3%	$3.2M-18.7%	$3.9M-2.9%	$4.0M+3.3%	$3.9M-8.1%	$4.2M+5.3%	$4.0M+31.5%	$3.0M+85.8%	$1.6M-42.6%	$2.9M+19.9%	$2.4M+4.0%	$2.3M
Long-Term Investments	$3.5Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M+334.5%	$4.8M0.0%	$4.8M0.0%	$4.8M
Total Liabilities	$8.6M+47.5%	$5.8M+22.5%	$4.7M+0.9%	$4.7M-26.8%	$6.4M-35.2%	$9.9M-8.7%	$10.8M+11.6%	$9.7M+1.4%	$9.6M-6.0%	$10.2M+26.2%	$8.1M-8.3%	$8.8M+39.6%	$6.3M+11.0%	$5.7M-14.1%	$6.6M
Current Liabilities	$8.5M+53.8%	$5.5M+21.7%	$4.5M+7.3%	$4.2M-30.6%	$6.1M-34.4%	$9.3M+4.4%	$8.9M+1.2%	$8.8M+10.2%	$8.0M-2.2%	$8.2M+8.4%	$7.5M-10.2%	$8.4M+44.6%	$5.8M+10.0%	$5.3M-10.7%	$5.9M
Non-Current Liabilities	$61K-77.9%	$279K+40.1%	$199K-57.6%	$469K+45.8%	$322K-46.8%	$605K-68.7%	$1.9M+110.2%	$921K-42.4%	$1.6M-21.4%	$2.0M+270.8%	$549K+29.2%	$425K-16.9%	$511K+24.0%	$412K-42.1%	$712K
Long-Term Debt	$61K-77.9%	$279Kn/m	$0-100.0%	$206K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$52.3M+5.6%	$49.5M+5.7%	$46.9M+2.1%	$45.9M+6.9%	$42.9M-5.0%	$45.1M+6.0%	$42.6M-1.5%	$43.2M+8.8%	$39.7M+11.2%	$35.7M+17.1%	$30.5M+10.6%	$27.6M+159.8%	$10.6M+3.7%	$10.2M+92.9%	$5.3M
Retained Earnings	-$7.0Mn/m	-$12.8Mn/m	-$18.0Mn/m	-$22.0Mn/m	-$25.9Mn/m	-$29.4Mn/m	-$32.9Mn/m	-$33.9Mn/m	-$37.2Mn/m	-$40.0Mn/m	-$43.0Mn/m	-$42.9Mn/m	-$36.3Mn/m	-$33.2Mn/m	-$32.6M

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Total Assets	$60.9M+10.0%	$57.4M+4.6%	$56.3M+2.9%	$55.6M+6.3%	$55.3M+7.2%	$54.8M+6.8%	$54.7M+8.8%	$52.3M+4.2%
Current Assets	$32.8M-2.8%	$33.1M+1.1%	$35.0M+7.9%	$34.1M+13.4%	$33.7M+15.0%	$32.8M+13.6%	$32.4M+17.5%	$30.1M+10.6%
Cash & Equivalents	$27.3M-4.6%	$26.4M-6.1%	$28.7M+2.4%	$28.8M+11.7%	$28.6M+13.6%	$28.1M+15.1%	$28.0M+20.6%	$25.8M+8.8%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Accounts Receivable	$4.6M+11.6%	$5.1M+41.7%	$4.9M+43.8%	$4.3M+31.6%	$4.1M+12.4%	$3.6M-4.7%	$3.4M-11.2%	$3.3M+9.1%
Long-Term Investments	$3.5Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M0.0%	$20.9M	$20.9M	$20.9M
Total Liabilities	$8.6M+47.5%	$6.9M+16.4%	$6.6M-3.1%	$5.4M+13.2%	$5.8M+22.5%	$5.9M+21.7%	$6.8M+48.3%	$4.8M+4.3%
Current Liabilities	$8.5M+53.8%	$6.8M+24.5%	$6.4M+2.7%	$5.2M+17.0%	$5.5M+21.7%	$5.4M+17.0%	$6.3M+46.4%	$4.5M+4.2%
Non-Current Liabilities	$61K-77.9%	$115K-76.0%	$170K-69.0%	$225K-35.3%	$279K+40.1%	$479K+122.2%	$549K+74.0%	$348K+5.7%
Long-Term Debt	$61K-77.9%	$115K-65.4%	$170K-55.6%	$225K+35.8%	$279Kn/m	$332K	$384K	$166K
Total Equity	$52.3M+5.6%	$50.5M+3.2%	$49.7M+3.7%	$50.2M+5.6%	$49.5M+5.7%	$48.9M+5.3%	$47.9M+4.8%	$47.5M+4.2%
Retained Earnings	-$7.0Mn/m	-$8.7Mn/m	-$10.3Mn/m	-$11.5Mn/m	-$12.8Mn/m	-$14.2Mn/m	-$15.7Mn/m	-$16.8Mn/m

Not reported in any period shown, so not listed: Inventory.

TRAK Cash Flow Statement

TRAK quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$8.2M-2.3%	$8.4M+20.9%	$7.0M-21.4%	$8.9M+45.2%	$6.1M+13.0%	$5.4M+28.7%	$4.2M-8.4%	$4.6M+110.1%	$2.2M-3.4%	$2.3M+348.5%	$503K-70.5%	$1.7Mn/m	-$93Kn/m	-$149K-117.2%	$867K
Depreciation & Amortization	$648K-48.3%	$1.3M+5.2%	$1.2M+10.2%	$1.1M+23.3%	$876K-14.1%	$1.0M+27.0%	$803K+33.5%	$601K-5.1%	$634K+30.4%	$486K-4.2%	$507K-33.9%	$768K-12.6%	$879K-2.4%	$901K+0.1%	$900K
Stock-Based Compensation	$445K+10.1%	$404K+10.0%	$367K-6.0%	$391K-7.4%	$422K+25.4%	$337K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	$17K+3.9%	$16K-78.2%	$73K-45.3%	$134K+163.5%	$51K-65.5%	$147K-77.4%	$650K-55.1%	$1.4M+609.7%	$204K-89.6%	$2.0M+2316.9%	$81K-78.1%	$370K-19.5%	$459K+3.0%	$446K+86.7%	$239K
Free Cash Flow	$8.2M-2.3%	$8.4M+22.0%	$6.9M-21.0%	$8.7M+44.2%	$6.1M+15.2%	$5.3M+48.2%	$3.5M+13.2%	$3.1M+58.5%	$2.0M+559.1%	$300K-29.0%	$422K-68.4%	$1.3Mn/m	-$552Kn/m	-$595K-194.7%	$628K
Investing Cash Flow	-$4.1M-2436198.2%	$169n/m	-$101Kn/m	-$903K-168.3%	$1.3Mn/m	-$319Kn/m	-$650Kn/m	-$970Kn/m	-$315Kn/m	-$2.0Mn/m	-$366Kn/m	-$2.6Mn/m	-$1.7Mn/m	-$446Kn/m	-$239K
Financing Cash Flow	-$5.4Mn/m	-$5.0Mn/m	-$5.7Mn/m	-$5.4Mn/m	-$10.0Mn/m	-$1.4Mn/m	-$1.8M-1773.8%	$108Kn/m	-$1.0M-144.5%	$2.3Mn/m	-$20K-100.2%	$8.9M+499.0%	$1.5M-52.3%	$3.1Mn/m	-$2.1M
Dividends Paid	$1.6M-1.2%	$1.7M-3.8%	$1.7M+21.7%	$1.4M+141.3%	$586K0.0%	$586K0.0%	$586K+33.3%	$440K-43.8%	$782K+7295.3%	$11K0.0%	$11K-93.3%	$157K-73.2%	$587K+16.6%	$503K+1.8%	$494K
Share Buybacks	$1.8M+799.1%	$200K-86.8%	$1.5M+15.8%	$1.3M-78.7%	$6.1M+369.9%	$1.3M-39.4%	$2.2M+347.4%	$482Kn/m	$0	N/A	N/A	N/A	N/A	$2.0M	N/A

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Operating Cash Flow	$2.4M+42.7%	$2.1M+45.2%	$2.2M-35.3%	$1.5M-17.7%	$1.7M-19.3%	$1.4M-41.6%	$3.5M+271.5%	$1.9M+22.9%
Depreciation & Amortization	$85K-75.0%	$95K-71.0%	$224K-26.5%	$244K-13.0%	$338K+15.7%	$329K+13.9%	$305K+1.6%	$280K-9.3%
Stock-Based Compensation	N/A	N/A	N/A	$101K+1.0%	N/A	N/A	N/A	$100K+17.2%
Capital Expenditures	$5K-32.4%	$0-100.0%	-$1n/m	$12Kn/m	$7K-87.1%	$9K+25.5%	$0-100.0%	$0n/m
Free Cash Flow	$2.4M+43.1%	$2.1M+46.1%	$2.2M-35.3%	$1.5M-18.3%	$1.6M-17.4%	$1.4M-41.8%	$3.5M+275.8%	$1.9M+22.9%
Investing Cash Flow	-$1.1Mn/m	-$3.0Mn/m	$21n/m	-$20K-159.7%	-$6Kn/m	-$13Kn/m	-$15Kn/m	$34Kn/m
Financing Cash Flow	-$453Kn/m	-$1.3Mn/m	-$2.3Mn/m	-$1.3Mn/m	-$1.2Mn/m	-$1.3Mn/m	-$1.2Mn/m	-$1.3Mn/m
Dividends Paid	$398K+26.6%	$411K-19.5%	$424K+3.8%	$403K-4.7%	$314K-27.8%	$510K+14.4%	$409K-2.4%	$423K+0.4%
Share Buybacks	$0-100.0%	$550Kn/m	$1.1M+998.4%	$150Kn/m	$100Kn/m	$0n/m	$100K-48.3%	$0-100.0%

TRAK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

TRAK quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	85.8%+2.1pp	83.7%+0.4pp	83.3%+0.6pp	82.7%+0.3pp	82.3%+15.1pp	67.2%+2.1pp	65.1%-7.4pp	72.5%+2.4pp	70.1%-1.8pp	71.9%+2.5pp	69.5%+8.0pp	61.5%+4.1pp	57.4%-3.0pp	60.3%+5.7pp	54.6%
Operating Margin	33.7%+6.1pp	27.6%+3.0pp	24.6%-2.1pp	26.7%+2.2pp	24.5%+10.7pp	13.8%+6.4pp	7.4%-11.5pp	18.8%+2.9pp	16.0%-4.6pp	20.6%+15.7pp	4.9%+34.9pp	-30.0%-8.2pp	-21.7%-25.3pp	3.5%+13.2pp	-9.6%
Net Margin	32.5%+1.6pp	30.9%+1.7pp	29.1%-0.1pp	29.3%+7.1pp	22.2%+2.6pp	19.6%+11.7pp	8.0%-10.5pp	18.4%+3.0pp	15.5%-4.5pp	20.0%-7.0pp	27.0%+55.2pp	-28.2%-7.3pp	-20.9%-23.2pp	2.3%+10.8pp	-8.5%
Return on Equity	14.5%+0.4pp	14.1%+1.4pp	12.7%+0.5pp	12.2%+2.9pp	9.3%+0.2pp	9.1%+5.4pp	3.7%-5.3pp	9.0%+0.4pp	8.6%-2.0pp	10.6%-1.8pp	12.4%+26.3pp	-14.0%+9.5pp	-23.4%-26.0pp	2.5%+18.7pp	-16.2%
Return on Assets	12.4%-0.2pp	12.6%+1.1pp	11.6%+0.5pp	11.1%+2.9pp	8.1%+0.6pp	7.5%+4.5pp	3.0%-4.4pp	7.4%+0.5pp	6.9%-1.3pp	8.2%-1.6pp	9.8%+20.4pp	-10.6%+4.1pp	-14.7%-16.3pp	1.6%+8.8pp	-7.2%
Current Ratio	3.85-2.2x	6.09-0.4x	6.450.0x	6.44+2.1x	4.36+1.2x	3.19+0.1x	3.050.0x	3.020.0x	2.97+0.7x	2.29+0.3x	1.97+0.4x	1.60+0.5x	1.11-0.1x	1.21+0.6x	0.60
Debt-to-Equity	0.000.0x	0.010.0x	0.000.0x	0.00	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Liabilities-to-Equity	0.160.0x	0.120.0x	0.100.0x	0.100.0x	0.15-0.1x	0.220.0x	0.250.0x	0.230.0x	0.240.0x	0.290.0x	0.27-0.1x	0.32-0.3x	0.590.0x	0.56-0.7x	1.25
Asset Turnover	0.380.0x	0.410.0x	0.400.0x	0.380.0x	0.370.0x	0.380.0x	0.380.0x	0.400.0x	0.450.0x	0.410.0x	0.360.0x	0.37-0.3x	0.700.0x	0.71-0.1x	0.85
FCF Margin	35.3%-1.9pp	37.2%+3.5pp	33.7%-12.0pp	45.7%+12.2pp	33.5%+8.5pp	25.0%+7.3pp	17.7%+2.9pp	14.8%+5.8pp	9.0%+7.4pp	1.6%-1.4pp	3.0%-6.8pp	9.8%+14.4pp	-4.6%+0.6pp	-5.3%-11.5pp	6.2%

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Gross Margin	85.7%+1.5pp	86.3%+1.8pp	85.4%+3.7pp	85.7%+1.5pp	84.2%+0.5pp	84.6%+0.9pp	81.7%+0.7pp	84.2%-0.7pp
Operating Margin	33.7%+6.2pp	38.3%+7.7pp	31.0%+6.4pp	31.7%+4.5pp	27.5%+2.0pp	30.6%+5.8pp	24.6%+0.4pp	27.2%+3.5pp
Net Margin	37.3%+6.1pp	33.8%+0.5pp	28.8%+0.5pp	30.5%-0.1pp	31.2%+0.7pp	33.2%+2.7pp	28.2%-0.1pp	30.6%+3.4pp
Return on Equity	4.0%+0.3pp	3.9%-0.1pp	3.4%+0.2pp	3.6%+0.1pp	3.6%+0.3pp	4.0%+0.7pp	3.2%+0.1pp	3.5%+0.5pp
Return on Assets	3.4%+0.2pp	3.5%-0.1pp	3.0%+0.2pp	3.3%+0.1pp	3.3%+0.2pp	3.6%+0.6pp	2.8%-0.1pp	3.2%+0.4pp
Current Ratio	3.85-2.2x	4.89-1.1x	5.45+0.3x	6.54-0.2x	6.09-0.4x	6.03-0.2x	5.18-1.3x	6.75+0.4x
Debt-to-Equity	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.010.0x	0.01	0.01	0.00
Liabilities-to-Equity	0.160.0x	0.140.0x	0.130.0x	0.110.0x	0.120.0x	0.120.0x	0.140.0x	0.100.0x
Asset Turnover	0.090.0x	0.100.0x	0.100.0x	0.110.0x	0.100.0x	0.110.0x	0.100.0x	0.100.0x
FCF Margin	42.3%+13.7pp	35.4%+11.3pp	38.2%-24.8pp	25.6%-8.8pp	28.6%-9.9pp	24.1%-24.1pp	63.0%+45.1pp	34.4%+4.3pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
ReposiTrak, Inc. TRAK	FY2026	$23.3M	$7.6M	32.5%	$133.2M	85/100
Materialise NV MTLS	FY2024	$276.1M	$13.9M	5.0%	$496.8M	50/100
A2Z Cust2Mate Solutions Corp. AZ	FY2025	$7.9M	-$37.7M	N/A	$246.5M	41/100
8x8, Inc. EGHT	FY2026	$735.8M	$1.6M	0.2%	$307.6M	32/100
Agora, Inc. API	FY2025	$141.1M	$9.5M	6.8%	$376.2M	49/100
Blaize Holdings, Inc. BZAI	FY2025	$38.6M	-$206.9M	N/A	$34.7M	37/100

Where ReposiTrak, Inc. Ranks

Frequently Asked Questions

What is ReposiTrak, Inc.'s annual revenue?

ReposiTrak, Inc. (TRAK) reported $23.3M in total revenue for fiscal year 2026. This represents a 3.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ReposiTrak, Inc.'s revenue growing?

ReposiTrak, Inc. (TRAK) revenue grew by 3.0% year-over-year, from $22.6M to $23.3M in fiscal year 2026.

Is ReposiTrak, Inc. profitable?

Yes, ReposiTrak, Inc. (TRAK) reported a net income of $7.6M in fiscal year 2026, with a net profit margin of 32.5%.

What is ReposiTrak, Inc.'s EBITDA?

ReposiTrak, Inc. (TRAK) had EBITDA of $8.5M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does ReposiTrak, Inc. have?

As of fiscal year 2026, ReposiTrak, Inc. (TRAK) had $27.3M in cash and equivalents against $61K in long-term debt.

What is ReposiTrak, Inc.'s gross margin?

ReposiTrak, Inc. (TRAK) had a gross margin of 85.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is ReposiTrak, Inc.'s operating margin?

ReposiTrak, Inc. (TRAK) had an operating margin of 33.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is ReposiTrak, Inc.'s net profit margin?

ReposiTrak, Inc. (TRAK) had a net profit margin of 32.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is ReposiTrak, Inc.'s return on equity (ROE)?

ReposiTrak, Inc. (TRAK) has a return on equity of 14.5% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is ReposiTrak, Inc.'s free cash flow?

ReposiTrak, Inc. (TRAK) generated $8.2M in free cash flow during fiscal year 2026. This represents a -2.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is ReposiTrak, Inc.'s operating cash flow?

ReposiTrak, Inc. (TRAK) generated $8.2M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are ReposiTrak, Inc.'s total assets?

ReposiTrak, Inc. (TRAK) had $60.9M in total assets as of fiscal year 2026, including both current and long-term assets.

What are ReposiTrak, Inc.'s capital expenditures?

ReposiTrak, Inc. (TRAK) invested $17K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Does ReposiTrak, Inc. buy back shares?

Yes, ReposiTrak, Inc. (TRAK) spent $1.8M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does ReposiTrak, Inc. have outstanding?

ReposiTrak, Inc. (TRAK) had 18M shares outstanding as of fiscal year 2026.

What is ReposiTrak, Inc.'s current ratio?

ReposiTrak, Inc. (TRAK) had a current ratio of 3.85 as of fiscal year 2026, which is generally considered healthy.

What is ReposiTrak, Inc.'s debt-to-equity ratio?

ReposiTrak, Inc. (TRAK) had a debt-to-equity ratio of 0.00 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is ReposiTrak, Inc.'s liabilities-to-equity ratio?

ReposiTrak, Inc. (TRAK) had a liabilities-to-equity ratio of 0.16 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is ReposiTrak, Inc.'s return on assets (ROA)?

ReposiTrak, Inc. (TRAK) had a return on assets of 12.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is ReposiTrak, Inc.'s P/E ratio?

ReposiTrak, Inc. (TRAK) trades at 17.6x earnings, its market capitalization divided by $7.6M net income, FY2026. The market capitalization is $133.2M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is ReposiTrak, Inc.'s price-to-sales ratio?

ReposiTrak, Inc. (TRAK) trades at 5.7x sales, its market capitalization divided by $23.3M revenue, FY2026. The market capitalization is $133.2M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is ReposiTrak, Inc.'s Altman Z-Score?

ReposiTrak, Inc. (TRAK) has an Altman Z-Score of 10.46, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is ReposiTrak, Inc.'s Piotroski F-Score?

ReposiTrak, Inc. (TRAK) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ReposiTrak, Inc.'s earnings high quality?

ReposiTrak, Inc. (TRAK) has an earnings quality ratio of 1.09x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can ReposiTrak, Inc. cover its interest payments?

ReposiTrak, Inc. (TRAK) has an interest coverage ratio of 203.81x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is ReposiTrak, Inc.?

ReposiTrak, Inc. (TRAK) scores 85 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.